Audiomedica.com
Randomized Study Confirms Rivaroxaban Oral Alternative For Cancer Thromboembolism
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:15:00
- Mas informaciones
Informações:
Sinopsis
ATLANTA—Six months follow up of the Select-D randomized open label multicenter pilot study with 406 patients has confirmed that therapy with the direct oral anticoagulant (DOAC) rivaroxaban was a safe and effective alternative strategy to standard treatment with the low …
